There are 113 papers on METS-IR in aging research: 107 observational studies in people, 6 reviews.
113 papers study it54 more mention it84 findings
22 new papers in 30 daysSee all 167 papers on METS-IR
“Individuals in the highest METS-IR quartile had a 3.65-fold higher risk of T2DM than those in the lowest (pooled HR/OR = 3.65, 95% CI: 2.33–5.72”
- Humans107
Interventions
4Atmospheric oxidants
upin humans1
1 study
Atmospheric oxidants
upin humans1
Atmospheric oxidants are linked with higher METS-IR in humans (+14.8% per 1-unit Ox increment).
“Each 1-unit Ox increment was associated with a 14.8% elevation in Metabolic Score for Insulin Resistance (METS-IR) in the early-onset”
Humans
Age-stratified susceptibility to atmospheric oxidant exposure and insulin resistance
Environmental pollution (Barking, Essex : 1987)
Occupational stress
upin humans1
1 study
Occupational stress
upin humans1
Occupational stress is linked with higher METS-IR in humans.
“compared with the Q1 group, METS-IR in Homo sapiens was higher in the Q2, Q3, and Q4 groups (P<0.05)”
Humansn = 1,910
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases
Bictegravir + emtricitabine + tenofovir alafenamide
upin humans1
1 study
Bictegravir + emtricitabine + tenofovir alafenamide
upin humans1
Bictegravir + emtricitabine + tenofovir alafenamide is linked with higher METS-IR in humans (people with HIV) (+0.3).
“and an increase of +0.3 with BIC ( P = 0.013)”
Humanspeople with HIV48 weeks
AIDS (London, England)
Doravirine + lamivudine + tenofovir disoproxil fumarate
downin humans1
1 study
Doravirine + lamivudine + tenofovir disoproxil fumarate
downin humans1
Doravirine + lamivudine + tenofovir disoproxil fumarate is linked with lower METS-IR in humans (people with HIV) (-0.9).
“Regarding METS-IR, after 48 weeks we observed a significant decrease in the DOR group (-0.9, P = 0.024)”
Humanspeople with HIV48 weeks
AIDS (London, England)
More on Doravirine + lamivudine + tenofovir disoproxil fumarate
Effects
5Cognitive function
downin humans2
2 studies
Cognitive function
downin humans2
METS-IR is linked with worse cognitive function in patients with non-disabling ischemic cerebrovascular events (P for overall = 0.014, P for non-linear = 0.715).
“RCS confirmed a linear negative correlation between METS-IR and MoCA scores”
Humansin patients with non-disabling ischemic cerebrovascular eventsn = 236
European journal of medical research
METS-IR is linked with worse cognitive function in humans.
“METS-IR was significantly negatively correlated with all cognitive function test scores.”
Humansafter adjusting for demographic characteristics, lifestyle factors, and metabolic-related diseases
European journal of medical research
Diabetes mellitus
no changein humans1HR 0.96
1 study
Diabetes mellitus
no changein humans1HR 0.96
METS-IR was not clearly linked with diabetes mellitus in humans (normal-weight, METS-IR >= 37.24) (HR 0.96, 95% CI: 0.89, 1.04).
“whereas above the threshold, the association was attenuated (HR: 0.96, 95% CI: 0.89, 1.04).”
Humansnormal-weight, METS-IR >= 37.24n = 23,692
Frontiers in nutrition
PhenoAge
mediatesin humans1
1 study
PhenoAge
mediatesin humans1
METS-IR is linked with PhenoAge in humans (20.23% in males, 8.73% in females).
“METS-IR partially mediated the FLI-BA association, with a greater percentage of mediation effect in males (PhenoAge: 20.23%; PhenoAgeAccel: 36.84%) than females (8.73%; 15.93%).”
Humans
Medicine
Frailty index
upin humans1
1 study
Frailty index
upin humans1
METS-IR is linked with higher frailty index in humans (β = 0.013 (95% CI = 0.004, 0.022)).
“participants in the highest quartile of METS-IR showed significantly greater FI progression, with β value of 0.013 (95% CI = 0.004, 0.022).”
Humansn = 6,722
Cardiovascular diabetology
Cardiovascular mortality
no changein humans1HR 1.14
1 study
Cardiovascular mortality
no changein humans1HR 1.14
METS-IR was not clearly linked with cardiovascular mortality in humans (adjusted for confounding variables) (HR 1.14, 95% CI 0.83-1.57).
“but not with cardiovascular mortality (HR, 1.14, 95% CI, 0.83-1.57) after adjustment for the same confounding variables.”
Humansadjusted for confounding variables
Frontiers in endocrinology
Upstream
125-hydroxyvitamin D2
no changein humans1
1 study
25-hydroxyvitamin D2
no changein humans1
25-hydroxyvitamin D2 was not clearly linked with METS-IR in humans (nationally representative sample).
“serum 25(OH)D2 levels were not significantly associated with the METS-IR.”
Humansnationally representative samplen = 9,297
Endocrine journal
Associations
44Type 2 diabetes
upin humans6HR 4.03
6 studies
Type 2 diabetes
upin humans6HR 4.03
METS-IR is linked with a higher risk of type 2 diabetes in humans (highest versus lowest category) (HR 4.03, 95% CI: 2.57-6.33).
“the highest METS-IR category was associated with a substantially elevated risk compared with the lowest category (HR = 4.03, 95% CI: 2.57-6.33)”
Humanshighest versus lowest category
Frontiers in endocrinology
METS-IR is linked with a higher risk of type 2 diabetes in humans (highest versus lowest quartile) (3.65-fold (95% CI 2.33–5.72)).
“Individuals in the highest METS-IR quartile had a 3.65-fold higher risk of T2DM than those in the lowest (pooled HR/OR = 3.65, 95% CI: 2.33–5.72”
Humanshighest versus lowest quartilen = 168,993
Research SquarePreprint
METS-IR is associated with type 2 diabetes in humans (obese adults (BMI ≥ 30 kg/m2)) (OR 2.51 (95% CI 1.60-3.93)).
“METS-IR remained associated with T2DM (OR 2.51; 95% CI 1.60-3.93; p < 0.001)”
Humansobese adults (BMI ≥ 30 kg/m2)n = 481
Archives of endocrinology and metabolism
METS-IR predicts type 2 diabetes in humans (AUC 0.688).
“METS-IR had the highest AUC (0.688).”
Humansup to 14.5 yearsn = 2,260
Scores from glucose drink tests best predicted type 2 diabetes
The Journal of clinical endocrinology and metabolism
METS-IR is linked with a higher risk of type 2 diabetes in humans (adjusted for covariates) (aHR 1.33, 95% CI 1.22-1.45).
“A SD unit increase in baseline METS-IR was associated with the first incidence of T2DM (adjusted hazard ratio [aHR] 1.33, 95% CI 1.22-1.45; P<.001) in all participants.”
Humansadjusted for covariates6.3 yearsn = 7,583
JMIR public health and surveillance
METS-IR is linked with a higher risk of type 2 diabetes in humans (aOR 1.804 (95% CI 1.720–1.891)).
“and T2DM (aOR = 1.804, 95%CI: 1.720 to 1.891, p < 0.001), respectively.”
Humansn = 18,112
International journal of environmental research and public health
Mortality
upin humans4mixedin humans1HR 1.08–1.222
5 studies
Mortality
upin humans4mixedin humans1HR 1.08–1.222
METS-IR is associated with mortality in humans (HR 1.222; 95% CI 1.020–1.465; threshold 49.4).
“When values exceeded this threshold, it demonstrated a positive correlation with all-cause mortality (HR 1.222; 95% CI: 1.020–1.465; p=0.030)”
HumansPatients with atherosclerotic cardiovascular disease and cardiometabolic conditions; METS-IR above 49.4Average follow-up 7.6±6.7 years78.8% malesn = 1,720
ESC Congress 2026 abstract
METS-IR is linked with a higher risk of mortality in humans (HR 1.08, 95% CI: 1.03-1.14).
“per 1-SD rise in METS-IR was linked to an 8% increased risk of all-cause death (HR = 1.08, 95% CI: 1.03-1.14)”
Humansper 1-SD rise
Frontiers in endocrinology
METS-IR is associated with mortality in humans (diabetes mellitus) (p-overall<0.0001, p-nonlinear<0.05).
“A U-shaped relationship was found between METS-IR, TyG-BMI, eGDR, and all-cause mortality (p-overall<0.0001, p-nonlinear<0.05).”
Humansdiabetes mellitus
ADA Scientific Sessions 2025 abstract
METS-IR is associated with mortality in humans (elderly diabetes patients) (p-overall < 0.0001, p-nonlinear < 0.05).
“A U-shaped relationship exists between METS-IR, TyG-BMI, eGDR, and all-cause mortality (p-overall < 0.0001, p-nonlinear < 0.05).”
Humanselderly diabetes patientsn = 1,248
Diabetology & metabolic syndrome
METS-IR is linked with a higher risk of mortality in humans (adjusted for metabolic parameters) (HR 1.16, 95% CI 1.01-1.34).
“The HRs of mortality for METS-IR tertiles were 1.16 (95% CI, 1.01-1.34) in T3 after adjustment for metabolic parameters”
Humansadjusted for metabolic parameters
Frontiers in endocrinology
Cardiovascular disease
upin humans3downin humans1HR 0.88–1.02
3 studies
Cardiovascular disease
upin humans3downin humans1HR 0.88–1.02
METS-IR is linked with a higher risk of cardiovascular disease in humans (METS-IR > 24.83) (HR 1.02, 95% CI 1.02–1.03).
“whereas above it, each unit increment conferred a 2% higher risk (HR 1.02, 95% CI 1.02–1.03, P < 0.0001).”
HumansMETS-IR > 24.83femalesn = 2,923
Research SquarePreprint
METS-IR is linked with a lower risk of cardiovascular disease in humans (METS-IR < 24.83) (HR 0.88, 95% CI 0.79–0.99).
“Below this threshold, higher METS-IR was associated with a significantly lower risk (HR 0.88, 95% CI 0.79–0.99, P = 0.0355)”
HumansMETS-IR < 24.83femalesn = 2,923
Research SquarePreprint
METS-IR is linked with a higher risk of cardiovascular disease in humans.
“Similarly, a higher TyG level and METS-IR were significantly associated with a higher incidence of CVD at both timeframes.”
Humans
Frontiers in endocrinology
METS-IR predicts cardiovascular disease in humans (NRI 0.175, IDI 0.006, P < 0.001).
“continuous net reclassification improvement and integrated discrimination improvement for predicting cardiovascular disease increased by 0.175 (P <0.001) and 0.006 (P <0.001), respectively.”
Humansn = 4,540
Frontiers in endocrinology
METS-IR is linked with a higher risk of cardiovascular disease in humans (per IQR increase) (OR 1.38, 95% CI 1.21-1.56).
“Each interquartile range (IQR) increased in Mets-IR raised the risk of developing CVD by 38% (OR=1.38; 95% CI, 1.21-1.56)”
Humansper IQR increasen = 4,540
Frontiers in endocrinology
Hypertension
upin humans3OR 1.54–3.48
3 studies
Hypertension
upin humans3OR 1.54–3.48
METS-IR is associated with hypertension in humans (obese adults (BMI ≥ 30 kg/m2)) (OR 1.81 (95% CI 1.13-2.91)).
“and HT (OR 1.81; 95% CI 1.13-2.91; p < 0.05).”
Humansobese adults (BMI ≥ 30 kg/m2)n = 481
Archives of endocrinology and metabolism
METS-IR predicts hypertension in humans (AUC 0.642 (95% CI 0.630-0.654)).
“The METS-IR index showed the highest discriminative performance among the indices, achieving an AUC of 0.642 (95% CI 0.630-0.654).”
Humansn = 9,438
European journal of medical research
METS-IR is associated with hypertension in humans after full adjustment (52.5% higher odds per 1-unit increase).
“each 1-unit increase in TyG, Tg/HDL-c, METS-IR, and CHG index was associated with 23.4%, 8.1%, 52.5%, and 9.9% higher odds of hypertension, respectively.”
Humansafter full adjustmentn = 9,438
European journal of medical research
METS-IR predicts hypertension in humans (OR = 1.54, 95% CI: 1.09, 2.18).
“each unit increase in METS-IR was significantly associated with increased hypertension incidence at 2 years (OR = 1.54, 95% CI: 1.09, 2.18, P < 0.05)”
Humans2 years
Aging clinical and experimental research
METS-IR is associated with hypertension in humans (adjusted OR = 3.48, 95% CI: 2.87, 4.21).
“each unit increase in METS-IR was associated with a threefold increase in the risk of hypertension (adjusted OR = 3.48, 95% CI: 2.87, 4.21, P < 0.0001)”
Humans
Aging clinical and experimental research
Diabetes mellitus
upin humans3+1% per unitHR 1.094–1.12
3 studies
Diabetes mellitus
upin humans3+1% per unitHR 1.094–1.12
METS-IR is linked with a higher risk of diabetes mellitus in humans (1% per unit).
“Mets-IR was 1 unit per liter, and the risk of new-onset diabetes increased by 1%.”
Humans
Medicine
METS-IR predicts diabetes mellitus in humans (predicting diabetes at 1 year) (AUC 0.601).
“The area under the curve (AUC) for METS-IR predicting diabetes was 0.601 (1 year), 0.586 (3 years), and 0.599 (5 years).”
Humanspredicting diabetes at 1 year1 yearn = 53,120
PloS one
METS-IR is linked with a higher risk of diabetes mellitus in humans (rural Chinese adults) (HR 1.094, 95% CI: 1.076-1.112).
“After multifactorial adjustment, METS-IR was significantly and positively associated with diabetes onset (hazard ratio (HR)=1.094,95% confidence interval (CI): 1.076-1.112, P < 0.001)”
Humansrural Chinese adultsmedian 3.83 yearsn = 53,120
PloS one
METS-IR is linked with a higher risk of diabetes mellitus in humans (normal-weight) (HR 1.12, 95% CI: 1.10, 1.14).
“each 1-unit rise in METS-IR corresponded to a 12% increase in diabetes risk (HR: 1.12, 95% CI: 1.10, 1.14).”
Humansnormal-weightn = 23,692
Frontiers in nutrition
Stroke
upin humans3HR 1.63
3 studies
Stroke
upin humans3HR 1.63
METS-IR is linked with a higher risk of stroke in humans.
“METS-IR was strongly related to stroke in individuals aged 20-40 in the stratification analysis.”
Humans
The International journal of neuroscience
METS-IR is linked with a higher risk of stroke in humans (nondiabetic adults) (adjusted HR = 1.63, 95% CI: 1.28–2.06).
“elevated METS-IR was dose-dependently associated with incident stroke (adjusted HR = 1.63, 95% CI: 1.28–2.06 for Q4 vs. Q1; p-trend < 0.0001)”
Humansnondiabetic adultsn = 8,316
BMC neurology
METS-IR is linked with a higher risk of stroke in humans (OR = 1.01, 95 % CI (1.01, 1.02), p < 0.001).
“Regression analysis indicated a positive association of METS-IR with stroke [NHANES: OR = 1.01, 95 % CI (1.01, 1.02), p < 0.001; CHARLS: OR = 1.02, 95 % CI (1.02, 1.03), p < 0.001]”
Humansn = 22,542
Experimental gerontology
Metabolic syndrome
upin humans2HR 1.16
2 studies
Metabolic syndrome
upin humans2HR 1.16
METS-IR predicts metabolic syndrome in humans (Metabolic syndrome defined according to ATP III/IDF criteria) (AUC 0.884; cut-off 42.8: sensitivity 83%, specificity 76%).
“METS-IR demonstrated excellent discriminatory capacity for metabolic syndrome (AUC 0.884).”
HumansMetabolic syndrome defined according to ATP III/IDF criterian = 4,690
ESC Congress 2026 abstract
METS-IR predicts metabolic syndrome in humans (AUC 0.740 (95% CI 0.713-0.768)).
“The area under the curve for MetS-IR in predicting MetS was 0.740 (95% CI 0.713-0.768), which was better than those of other indicators.”
Humansmedian of 27.70 monthsn = 1,498
Frontiers in public health
METS-IR is linked with a higher risk of metabolic syndrome in humans (HR 1.16, 95% CI 1.13-1.18 per 1-SD increment).
“The adjusted multivariable Cox regression analysis indicated an elevated 15% risk of developing MetS for 1-SD increment of MetS-IR [hazard ratios (HRs) and 95% confidence intervals: 1.16 (1.13-1.18)].”
Humansmedian of 27.70 monthsn = 1,498
Frontiers in public health
Cardiometabolic multimorbidity
upin humans2+4% elevated risk per unit increaseOR 2.94
2 studies
Cardiometabolic multimorbidity
upin humans2+4% elevated risk per unit increaseOR 2.94
METS-IR is linked with a higher risk of cardiometabolic multimorbidity in humans (per unit increase) (4% elevated risk per unit increase).
“Every unit increase in METS-IR correlated with a 4% elevated risk of CMM in both groups.”
Humansper unit increase
Nutrition & metabolism
METS-IR is linked with a higher risk of cardiometabolic multimorbidity in humans (baseline METS-IR, highest vs lowest tertile) (OR 2.94, 95%CI 2.04–4.22).
“Participants in the highest METS-IR tertile showed a significantly increased risk of developing CMM compared to those in the lowest tertile (baseline: OR 2.94, 95%CI 2.04–4.22”
Humansbaseline METS-IR, highest vs lowest tertile6-year follow-up
BMC public health
Cognitive impairment
upin humans2OR 1.014–1.564
2 studies
Cognitive impairment
upin humans2OR 1.014–1.564
METS-IR is linked with a higher risk of cognitive impairment in humans (OR = 1.564, 95% CI = 1.220-2.005).
“participants in Q3 and Q4 of METS-IR had 1.375-fold and 1.564-fold higher risks of CI, respectively, compared with those in Q1”
Humansn = 5,842
Journal of Alzheimer's disease : JAD
METS-IR is linked with a higher risk of cognitive impairment in humans (fully adjusted model) (OR = 1.014, 95% CI: 1.004-1.023).
“for each unit increase in the METS-IR index, the risk of cognitive impairment increased by 1.4% (OR = 1.014, 95% CI: 1.004-1.023; p < 0.01).”
Humansfully adjusted modeln = 12,307
Frontiers in public health
Osteoporosis
downin humans1upin humans1HR 0.929
2 studies
Osteoporosis
downin humans1upin humans1HR 0.929
METS-IR is linked with a lower risk of osteoporosis in humans (adjusted Cox regression) (HR 0.929, 95% CI 0.892-0.968).
“and 0.929 (95%CI 0.892-0.968), respectively, and pre-sented at linear dose-response relationships”
Humansadjusted Cox regression2015 until 2022malesn = 1,622
Role of TyG, TyG-BMI and METS-IR in osteoporosis risk among older men: a retrospective cohort study
Asia Pacific journal of clinical nutrition
METS-IR predicts osteoporosis in humans (non-type 2 diabetes).
“these three indexes of insulin resistance metabolism had certain predictive value in osteoporosis, among which METS-IR had the highest diagnostic value in osteoporosis.”
Humansnon-type 2 diabetesn = 700
Research SquarePreprint